Richard Scott Struthers

Insider Reports History

Entity
Individual
Location
C/O Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Bldg. #2, San Diego, CA
Signature
Marc Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Scott Struthers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 571K $28.2M $49.40 May 8, 2024 By Family Trust 1
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 257K $12.7M $49.40 May 8, 2024 Direct
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 110K $5.43M $49.40 May 8, 2024 By Family Trust 2
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 110K $5.43M $49.40 May 8, 2024 By Family Trust 3
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 110K $5.43M $49.40 May 8, 2024 By Family Trust 4
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 1K $49.4K $49.40 May 8, 2024 By Spouse
Crinetics Pharmaceuticals, Inc. President & CEO, Director Incentve stock option (Right to Buy) 151K Aug 14, 2023 Direct
Crinetics Pharmaceuticals, Inc. President & CEO, Director Incentive stock option (Right to Buy) 101K Nov 9, 2023 Direct
Crinetics Pharmaceuticals, Inc. President & CEO, Director Stock Option (Right to Buy) 16.3K May 8, 2024 Direct

Insider Reports Filed by Richard Scott Struthers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRNX Crinetics Pharmaceuticals, Inc. May 8, 2024 3 -$4.31M 4 May 10, 2024 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Apr 18, 2024 1 $0 4 Apr 22, 2024 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Apr 15, 2024 2 $38.2K 4 Apr 17, 2024 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Apr 4, 2024 3 -$1.63M 4 Apr 8, 2024 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Mar 18, 2024 1 -$484K 4 Mar 20, 2024 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Mar 4, 2024 2 $0 4 Mar 6, 2024 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Feb 12, 2024 4 $0 4 Feb 14, 2024 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Nov 9, 2023 2 $95.5K 4 Nov 13, 2023 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Nov 2, 2023 6 -$4.26M 4 Nov 6, 2023 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Aug 14, 2023 2 $19.1K 4 Aug 16, 2023 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Jul 11, 2023 3 -$1.01M 4 Jul 13, 2023 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 16, 2023 1 -$1.04M 4 Jun 21, 2023 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Mar 16, 2023 1 -$79.2K 4 Mar 17, 2023 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Oct 12, 2022 2 $21.2K 4 Oct 14, 2022 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Apr 13, 2022 3 -$3.72M 4 Apr 15, 2022 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Apr 5, 2022 1 -$541K 4 Apr 7, 2022 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Feb 28, 2022 2 $0 4 Mar 2, 2022 President & CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Sep 7, 2021 3 -$750K 4 Sep 9, 2021 President & CEO, Director